The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre Ltd, sold 2,29,870 equity shares (0.14% of the company's share capital) through open market transactions on August 28 and 29, 2025. His personal holding came down from 52,96,890 shares (3.25%) to 50,67,020 shares (3.11%). The disclosure has been filed under Regulation 29(2) of SEBI's Takeover Regulations, which applies to promoter share sales. Persons Acting in Concert with him, including a family trust and immediate family members, together hold 93,01,000 shares (5.71%), bringing the broader promoter group's combined effective stake to roughly 8.82%.
This is a small, routine open-market sale by one promoter and is unlikely to move the stock price or change control of the company. Retail investors should note the slow trimming of promoter stake, but the quantum is too small to materially affect investor sentiment or shareholder value.